Dan Henrohn

2.2k total citations
27 papers, 774 citations indexed

About

Dan Henrohn is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Dan Henrohn has authored 27 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Physiology. Recurrent topics in Dan Henrohn's work include Pulmonary Hypertension Research and Treatments (9 papers), Dermatology and Skin Diseases (5 papers) and Allergic Rhinitis and Sensitization (5 papers). Dan Henrohn is often cited by papers focused on Pulmonary Hypertension Research and Treatments (9 papers), Dermatology and Skin Diseases (5 papers) and Allergic Rhinitis and Sensitization (5 papers). Dan Henrohn collaborates with scholars based in Sweden, United States and Denmark. Dan Henrohn's co-authors include Margareta Hammarlund‐Udenaes, Anna Alassaad, Ulrika Gillespie, Håkan Melhus, Claes Mörlin, Henrik Toss, Hans Garmo, Åsa Kettis-Lindblad, Gerhard Wikström and Maria Bertilsson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

Dan Henrohn

24 papers receiving 749 citations

Peers

Dan Henrohn
Brandon Brown United States
H. Hamilton Ireland
Karl Matuszewski United States
Donald G. Pittman United States
Ginah Nightingale United States
Audrey J. Lee United States
Brandon Brown United States
Dan Henrohn
Citations per year, relative to Dan Henrohn Dan Henrohn (= 1×) peers Brandon Brown

Countries citing papers authored by Dan Henrohn

Since Specialization
Citations

This map shows the geographic impact of Dan Henrohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Henrohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Henrohn more than expected).

Fields of papers citing papers by Dan Henrohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Henrohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Henrohn. The network helps show where Dan Henrohn may publish in the future.

Co-authorship network of co-authors of Dan Henrohn

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Henrohn. A scholar is included among the top collaborators of Dan Henrohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Henrohn. Dan Henrohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kapetanovic, Meliha C, et al.. (2025). Vaccine Knowledge and Awareness Among Patients With Chronic Inflammatory Diseases: Results From a Nordic Survey. Journal of Patient Experience. 12. 692869861–692869861.
2.
Kobyletzki, Laura von, Dan Henrohn, Natalia Ballardini, et al.. (2023). Comorbidities in childhood atopic dermatitis: A population‐based study. Journal of the European Academy of Dermatology and Venereology. 38(2). 354–364. 8 indexed citations
3.
Molander, Pauliina, Jyrki Tillonen, Aki Juhani Käräjämäki, et al.. (2023). Tofacitinib real-world experience in ulcerative colitis in Finland (FinTofUC): a retrospective non-interventional multicenter patient chart data study. Scandinavian Journal of Gastroenterology. 59(4). 425–432. 2 indexed citations
4.
Kobyletzki, Laura von, Natalia Ballardini, Dan Henrohn, et al.. (2022). Care pathways in atopic dermatitis: a retrospective population‐based cohort study. Journal of the European Academy of Dermatology and Venereology. 36(9). 1456–1466. 9 indexed citations
5.
Winthrop, Kevin, Arne Yndestad, Dan Henrohn, et al.. (2022). Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs. Rheumatology and Therapy. 10(2). 357–373. 3 indexed citations
6.
Ortsäter, Gustaf, Jacob P. Thyssen, Laura B. von Kobyletzki, et al.. (2022). Societal economic burden and determinants of costs for atopic dermatitis. SHILAP Revista de lepidopterología. 1(4). 326–343.
8.
Ortsäter, Gustaf, Jacob P. Thyssen, Laura von Kobyletzki, et al.. (2022). Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases. Dermatology and Therapy. 12(2). 545–559. 6 indexed citations
9.
Ortsäter, Gustaf, Joseph C. Cappelleri, Amy Cha, et al.. (2020). Clinical and Economic Burden of Pediatric Mild-to-Moderate Atopic Dermatitis: A Population-Based Nested Case–Control Study in Sweden. Dermatology and Therapy. 11(1). 161–172. 8 indexed citations
10.
Carlström, Mattias, et al.. (2019). Effects of inorganic nitrate in a rat model of monocrotaline‐induced pulmonary arterial hypertension. Basic & Clinical Pharmacology & Toxicology. 126(2). 99–109. 5 indexed citations
12.
Schneede, Jørn, David Kylhammar, Dan Henrohn, et al.. (2017). Plasma l-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction. Heart and Vessels. 33(3). 255–263. 20 indexed citations
14.
15.
Henrohn, Dan, et al.. (2012). Acute haemodynamic response in relation to plasma vardenafil concentrations in patients with pulmonary hypertension. British Journal of Clinical Pharmacology. 74(6). 990–998. 5 indexed citations
16.
Henrohn, Dan, et al.. (2012). High inter-individual variability of vardenafil pharmacokinetics in patients with pulmonary hypertension. European Journal of Clinical Pharmacology. 69(2). 197–207. 8 indexed citations
17.
Malinovschi, Andreï, et al.. (2011). Increased plasma and salivary nitrite and decreased bronchial contribution to exhaled NO in pulmonary arterial hypertension. European Journal of Clinical Investigation. 41(8). 889–897. 14 indexed citations
18.
Henrohn, Dan, Fredrik Rorsman, Johan Lennartsson, et al.. (2009). Lack of evidence of stimulatory autoantibodies to platelet‐derived growth factor receptor in patients with systemic sclerosis. Arthritis & Rheumatism. 60(4). 1137–1144. 72 indexed citations
19.
Gillespie, Ulrika, Anna Alassaad, Dan Henrohn, et al.. (2009). A Comprehensive Pharmacist Intervention to Reduce Morbidity in Patients 80 Years or Older. Archives of Internal Medicine. 169(9). 894–894. 9 indexed citations
20.
Henrohn, Dan, Pierre Le Grevès, & Fred Nyberg. (1997). Morphine alters the levels of growth hormone receptor mRNA and [125I]growth hormone binding in human IM-9 lymphoblasts via a naloxone-reversible mechanism. Molecular and Cellular Endocrinology. 135(2). 147–152. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026